-
-
-
-
-
-
-
MiNK Therapeutics (INKT) Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
-
-
-
-
-
-
-
Petros Pharmaceuticals, Inc (PTPI) Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
-
-
-
-
-
-
-
Eli Lilly (LLY): More than one-half of patients with Crohn's disease treated with mirikizumab achieved clinical remission at one year
-
-
-
-
-
-
-
Citius Pharmaceuticals (CTXR) Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution
-
-
-
-
-
-
-
GRI Bio, Inc (GRI) Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis
-
-
-
-
-
-
-
Dyne Therapeutics (DYN) Announces New Clinical Data from ACHIEVE Trial of DYNE-101
-
-
-
-
-
-
-
Achieve Life Sciences (ACHV) Announces Data from Cytisinicline ORCA-V1 Program to be Presented
-
67,131 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.